timi phase i compared the efficacy of recombinant tissue-type plasminogen activator ( rt-pa ) with that of streptokinase ( sk ) in a randomized double blind trial , using 80 mg rt-pa or 1.5 million units sk within 7 hours of clinical onset of infarction . rt-pa recanalized infarct related arteries in 62 % compared to 31 % with streptokinase .
C0027051
timi
C0032143
rt-pa